Home » Topics » Regulatory » Patents

Patents
RSS

Dainippon reveals compounds with antitumor activity

May 31, 1996

Spicamycin derivative revealed

May 31, 1996

Otsuka reveals matrix metalloproteinase inhibitors

May 31, 1996

Merck & Co. reveals protein farnesyltransferase-inhibiting analogues

May 31, 1996

Ruthenium complexes revealed by Procept

May 31, 1996

Zeneca claims prostaglandin E antagonists

May 31, 1996

Merck Frosst Canada reveals cyclooxygenase type 2 (COX-2) inhibitors

May 31, 1996

Di-tert-butylphenol compounds from Proctor & Gamble

May 31, 1996

Bayer announces formulation of antibacterial agents

May 31, 1996

Retinoid antagonists revealed by Eisai

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.